Consistent with U251, the time-course immunocytochemical analysis with neuronal markers DCX, TUBB3 and MAP2, showed that ASCL1 alone could also rapidly and efficiently reprogram U87 human glioma cells into neuron-like cells (Supplementary Figure S3). This evidence concerns the gene MAP2 and central nervous system cancer.